ABcann Global Announces Inclusion on the Horizons Medical Marijuana Life Sciences ETF
2017年7月5日 - 9:55PM
ABcann Global Corporation (TSX-V:ABCN)
("
ABcann" or the "
Company") is
pleased to announce its inclusion in the Horizons Medical Marijuana
Life Sciences ETF (TSX:HMMJ) (the “
ETF”).
The ETF is the first of its kind and offers
investors direct exposure to a basket of North American publicly
listed life sciences companies with significant business activities
in the medical marijuana sector. The ETF is an index (or passively
managed) ETF, which seeks to replicate, to the extent possible, the
performance of the North American Medical Marijuana Index (the
“Index”), net of expenses. The Index selects from
a current universe of companies that have operations that may
include one or more of biopharmaceuticals, medical manufacturing,
distribution, bioproducts and other ancillary businesses to the
marijuana industry.
Only stocks that meet minimum asset and
liquidity thresholds are eligible for inclusion in the Index.
Stocks are rebalanced quarterly on a market-capitalization basis,
and capped so that no single stock can exceed 10% of the weight of
the Index when rebalanced.
“The Horizons ETF represents a new type of
investment, a fund that tracks an industry in which there is
considerable interest but which had no prior investment vehicle
through which investors could gain broad exposure,” says Aaron
Keay, CEO of ABcann. “Our inclusion in the ETF represents an
important milestone for our company as we strive to become a
dominant industry participant.”
About ABcann Global Corporation
(TSX-V:ABCN):
ABcann was one of the first companies to obtain
a production license under the Marijuana for Medical Purposes
Regulations, which it received on March 21, 2014. It obtained a
sales license on December 31, 2015. ABcann’s flagship facility, in
Napanee, Ontario, contains proprietary plant-growing technology,
including environmentally-controlled chambers capable of monitoring
and regulating all variables in the growing process. This approach
and the systems in place allow ABcann to produce organically grown
and pesticide-free, high-yielding plants, which, in turn, can
generate high-quality products that are consistent from batch to
batch. ABcann is able to control environmental and nutrient
demands, tailor-made for a particular strain of cannabis, without
the variation that is typical when producing large quantities in
less-controlled, larger rooms and greenhouse-type structures.
ABcann’s modular approach to systems technology eliminates scale-up
risk and allows ABcann to locate anywhere in the world and maintain
consistency and quality of product.
ABcann is expanding capacity in its current
facility to approximately 30,000 sq ft and concurrently undertaking
expansion into a new 150,000 sq ft facility in Napanee. ABcann is
pursuing opportunities in Germany, Australia and other
jurisdictions as well as exploring the development of multiple
delivery vehicles.
About Horizons ETFs Management (Canada)
Inc.
Horizons ETFs Management (Canada) Inc. and its
affiliate, AlphaPro Management Inc., are innovative financial
services companies offering the Horizons ETFs family of exchange
traded funds. The Horizons ETFs family includes a broadly
diversified range of investment tools with solutions for investors
of all experience levels to meet their investment objectives in a
variety of market conditions. Horizons ETFs have more than $7
billion of assets under management. With 77 ETFs listed on the
Toronto Stock Exchange, the Horizons ETFs family makes up one of
the largest families of ETFs in Canada. Horizons ETFs Management
(Canada) Inc. and AlphaPro Management Inc. are members of the Mirae
Asset Global Investments Group.
ON BEHALF OF THE BOARD OF DIRECTORS
"Aaron Keay"
Aaron Keay CEO and Director
For further information, please contact Aaron Keay by phone at
(604) 323-6911 or by email at aaron@ABcannglobal.com, or Leo
Karabelas by phone at (416) 543-3120 or by email at
leo.k@ABcannglobal.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are
forward-looking statements, which are statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future. Forward
looking statements in this news release include statements relating
to the scope of the Company’s proposed expansions at its Napanee
facilities. Such statements are subject to risks and uncertainties
that may cause actual results, performance or developments to
differ materially from those contained in the statements,
including: (i) changes to applicable legislation or regulatory
requirements; (ii) changes to the anticipated costs of the
expansions that require the Company to obtain additional capital or
modify its development plans; and (iii) other factors beyond the
Company's control. No assurance can be given that any of the events
anticipated by the forward-looking statements will occur or, if
they do occur, what benefits the Company will obtain from them.
Readers are urged to consider these factors, and the more extensive
risk factors included in the Company’s filing statement dated March
31, 2017 which is available on SEDAR, carefully in evaluating the
forward-looking statements contained in this news release and are
cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. The forward-looking statements in this news
release are made as of the date hereof and the Company disclaims
any intent or obligation to update publicly any such
forward-looking statements, whether as a result of new information,
future events or results or otherwise, except as required by
applicable securities laws.
Global X Marijuana Life ... (TSX:HMMJ)
過去 株価チャート
から 12 2024 まで 1 2025
Global X Marijuana Life ... (TSX:HMMJ)
過去 株価チャート
から 1 2024 まで 1 2025